Thymic function and allogeneic T-cell responses in stem-cell transplantation

Cytotherapy

Volumn 4, Issue 4, 2002, Pages 333-342

  Komanduri, Krishna V ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

Immune reconstitution; Stem cell transplantation; Thymus

Indexed keywords

ANTINEOPLASTIC AGENT; ANTIRETROVIRUS AGENT; CYCLOSPORIN; CYTOTOXIC AGENT; STEROID; T LYMPHOCYTE RECEPTOR; TACROLIMUS; THYMOCYTE ANTIBODY;

ADOPTIVE IMMUNOTHERAPY; ADULTHOOD; ALLOIMMUNITY; ALLOTRANSPLANTATION; AUTOTRANSPLANTATION; CANCER; CELL MATURATION; CELL SELECTION; CELL SPECIFICITY; CELL SURVIVAL; CELLULAR IMMUNITY; CHILDHOOD CANCER; CHIMERA; CLINICAL OBSERVATION; DONOR; GRAFT VERSUS HOST REACTION; HLA SYSTEM; HOMEOSTASIS; HOST CELL; HOST PATHOGEN INTERACTION; HOST RESISTANCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; IMMUNOPHENOTYPING; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOCYTE MIGRATION; LYMPHOCYTOPOIESIS; LYMPHOID CELL; MEDIATOR; NONHUMAN; PERIPHERAL LYMPHOCYTE; RECIPIENT; REVIEW; STEM CELL; STEM CELL TRANSPLANTATION; T LYMPHOCYTE; THYMUS DISEASE; THYMUS FUNCTION;

EID: 0036384941     PISSN: 14653249     EISSN: None     Source Type: Journal    
DOI: 10.1080/146532402760271118     Document Type: Article

References (92)

1. Miller JFAP. Immunological function of the thymus. Lancet 1961;2:748-9.
2. Miller JFAP. Immunological significance of the thymus of the adult mouse. Nature 1962;195:1318-19.
3. Gowans JL, McGregor DD, Cowen DM, Ford CE. Initiation of immune responses by small lymphocytes. Nature 1962;196:651-5.
4. Miller JF, Mitchell GF. The thymus and the precursors of antigen reactive cells. Nature 1967;216:659-63.
5. Weissman IL. Thymus cell maturation. Studies on the origin of cortisone-resistant thymic lymphocytes. J Exp Med 1973;137:504-10.
6. Fathman CG, Small M, Herzenberg LA, Weissman IL. Thymus cell maturation. II. Differentiation of three 'mature' subclasses in vivo. Cell Immunol 1975;15:109-28.
7. Züniga-Pflucker JC, Lenardo MJ. Regulation of thymocyte development from immature progenitors. Curr Opin Immunol 1996;8:215-24.
8. Wu L, Scollay R, Egerton M et al. CD4 expressed on earliest T-lineage precursor cells in the adult murine thymus. Nature 1991;349:71-4.
9. Godfrey DI, Kennedy J, Mombaerts P et al. Onset of TCR β gene rearrangement and role of TCR β expression during CD3CD4 CD8 thymocyte differentiation. J Immunol 1994;152:4783-92.
10. Saint-Ruf C, Ungewiss K, Groettrup M et al. Analysis and expression of a cloned pre-T cell receptor gene. Science 1994;266:1208-12.
11. Owen MJ, Venkitaraman AR. Signalling in lymphocyte development. Curr Opin Immunol 1996;8:191-8.
12. Trigueros C, Ramiro AR, Carrasco YR et al. Identification of a late stage of small noncycling pT-α negative T cells as immediate precursors of T cell receptor αβ thymocytes. J Exp Med 1998;188:1401-12.
13. Kraft DL, Weissman IL, Waller EK. Differentiation of CD3-4-8- human fetal thymocytes in vivo: characterization of a CD3-4+8- intermediate. J Exp Med 1993;178:265-77.
14. + T cells. Curr Opin Immunol 1996;8:225-32.
15. Benoist C, Mathis D. Positive selection of T cells: fastidious or promiscuous? Curr Opin Immunol 1997;9:245-9.
16. Marrack P, Kappler J. Positive selection of thymocytes bearing αβ T cell receptors. Curr Opin Immunol 1997;9:250-5.
17. Lucas B, Germain RN. T-cell repertoire: political correctness in the immune system. Curr Biol 1996;6:783-7.
18. van Meerwijk JPM, Marguerat S, Lees RK et al. Quantitative impact of thymic clonal deletion on the T cell repertoire. J Exp Med 1997;185:377-84.
19. c reactive T cells. Nature 1988;335:827-30.
20. Choi YW, Herman A, DiGiusto D et al. Residues of the variable region of the T-cell-receptor β-chain that interact with S. aureus toxin superantigens. Nature 1990;346:471-3.
21. Choi Y, Kappler JW, Marrack P. A superantigen encoded in the open reading frame of the 3′ long terminal repeat of mouse mammary tumour virus. Nature 1991;350:203-7.
22. Kappler JW, Staerz U, White J, Marrack PC. Self-tolerance eliminates T cells specific for Mls-modified products of the major histocompatibility complex. Nature 1988;332:35-40.
23. Pullen AM, Marrack P. Kappler JW. The T-cell repertoire is heavily influenced by tolerance to polymorphic self-antigens. Nature 1988;335:796-801.
24. Jenkinson EJ, Anderson C, Owen JJ. Studies on T-cell maturation on defined thymic stromal cells in vitro. J Exp Med 1992;176:845-53.
25. Baccala R, Vandekerckhove BA, Jones D et al. Bacterial superantigens mediate T cell deletions in the mouse severe combined immunodeficiency-human liver/thymus model. J Exp Med 1993;177:1481-5.
26. Wailer EK, Sen-Majumdar A, Kamel OW et al. Human T-cell development in SCID-hu mice: staphylococcal enterotoxins induced specific clonal deletions, proliferation, and energy. Blood 1992;80:3144-56.
27. Komanduri KV, Salha MD, Sékaly RP, McCune JM. Superantigen mediated deletion of specific T cell receptor Vβ subsets in the SCID-hu Thy/Liv mouse is induced by staphylococcal enterotoxin B, but not HIV-1. J Immunol 1997;158:544-9.
28. Owen JJ, Moore NC. Thymocyte-stromal-cell interactions and T-cell selection. Immunol Today 1995;16:336-8.
29. Sprent J, Webb SR. Intrathymic and extrathymic cional deletion of T cells. Curr Opin Immunol 1995;7:196-205.
30. Vandekerckhove BA, Namikawa R, Bacchetta R, Roncarolo MG. Human hematopoietic cells and thymic epithelial cells induce tolerance via different mechanisms in the SCID-hu mouse thymus. J Exp Med 1992;175:1033-43.
31. Klein L, Klein T, Rüther U, Kyewski B. CD4 T cell tolerance to human C-reactive protein, an inducible serum protein, is mediated by medullary thymic epithelium. J Exp Med 1998;188:5-16.
32. Pugliese A, Zeller M, Fernandez A Jr et al. The insulin gene is transcribed in the human thymus and transcription levels correlate with allelic variation at the INS VNTR-IDDM2 susceptibility locus for type 1 diabetes. Nat Genet 1997;15:
33. Vafiadis P, Bennet ST, Todd JA et al. Insulin expression in human thymus is modulated by INS VNTR alleles at the IDDM2 locus. Nat Gen 1997;15:
34. Egwuagu CE, Charukamnoetkanok F, Gery I. Thymic expression of autoantigens correlates with resistance to autoimmune disease. J Immunol 1997;159:3109-12.
35. Heath V, Mason D, Ramirez F, Seddon B. Homeostatic mechanisms in the control of autoimmunity. Sem Immunol 1997;9:375-80.
36. Khouri IF, Keating M, Korbling M et al. Transplant-lite: induction of graft-versus malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies. J Clin Oncol 1998;16:2817-24.
37. Champlin R, Khouri I, Kornblau S et al. Reinventing bone marrow transplantation: reducing toxicity using non-myeloablative, preparative regimens and induction of graft-versus-malignancy. Curr Opin Oncol 1999;11:87-95.
38. Eisner M, August C. Impact of donor and recipient characteristics on the development of acute and chronic graft-versus-host disease following pediatric bone marrow transplantation. Bone Marrow Transplant 1995;15:663-8.
39. Yamada K, Choo JK, Allan JS et al. The effect of thymectomy on tolerance induction and cardiac allograft vasculopathy in a miniature swine heart/kidney transplantation model. Transplantation 1999;68:485-91.
40. Noris M, Cugini D, Casiraghi F et al. Thymic microchimerism correlates with the outcome of tolerance-inducing protocols for solid organ transplantation. J Am Soc Nephrol 2001;12:2815-26.
41. Chau LA, Rohekar S, Wang JJ et al. Thymic re-entry of mature activated T cells and increased negative selection in vascularized allograft recipients. Clin Exp Immunol 2002;127:43-52.
42. Gopinathan R, DePaz HA, Oluwole OO et al. Role of re-entry of in vivo a11oMHC peptide-activated T cells into the adult thymus in acquired systemic tolerance. Transplantation 2001;72:1533-41.
43. Li Y, Hisha H, Inaba M et al. Evidence for migration of donor bone marrow stromal cells into recipient thymus after bone marrow transplantation plus bone grafts: a role of stromal cells in positive selection. Exp Hematol 2000;28:950-60.
44. Bell EB, Sparshott SM. The peripheral T-cell pool: regulation by non-antigen induced proliferation? Sem Immunol 1997;9:347-53.
45. + T cell pools. Eur J Immunol 1995;25:2127-36.
46. Mackall CL, Gress RE. Pathways of T-cell regeneration in mice and humans: implications for bone marrow transplantation and immunotherapy. Immunol Rev 1997;157:61-72.
47. Mackall CL, Hakim FT. Gress RE. Restoration of T-cell homeostasis after T-cell depletion. Sem Immunol 1997;9:339-46.
48. Mackall CL, Granger L, Sheard MA et al. T-cell regeneration after bone marrow transplantation: differential CD45 isoform expression on thymic-derived versus thymic-independent progeny. Blood 1993;82:2585-94.
49. Mackall CL, Bare CV, Cranger LA et al. Thymic-independent T cell regeneration occurs via antigen-driven expansion of peripheral T cells resulting in a repertoire that is limited in diversity and prone to skewing. J Immunol 1996;156:4609-16.
50. + T cell frequencies by flow cytometry: Evidence for a novel, antigen-specific homeostatic mechanism in HIV-associated immunodeficiency. J Clin Invest 1997;99:1739-50.
51. + T lymphocyte responses after ganciclovir and highly active antiretroviral therapy in individuals as infected with HIV-1. Nat Med 1998;4:953-6.
52. McCune JM. Thymic function in HIV-1 disease. Sem Immunol 1997;9:397-404.
53. Steinmann GG. Changes in the human thymus during aging. Curr Top Pathol 1986;75:43-88.
54. Moore AV, Korobkin M, Olanow W et al. Age-related changes in the thymus gland: CT-pathologic correlation. Am J Radiol 1983;141:?
55. Francis JR Glazer GM, Brookstein FL, Gross BH, The thymus: Reexamination of age-related changes in size and shape. Am J Radiol 1985;145:249-54.
56. Dixon AK, Hilton CJ, Williams GT. Computed tomography and histological correlation of the thymic remnant. Clin Radiol 1981;32:255-7.
57. Lum LG. The kinetics of immune reconstitution after human marrow transplantation. Blood 1987;69:369-80.
58. Parkman R, Weinberg KI. Immunological reconstitution following bone marrow transplantation. Immunol Rev 1997;157:73-8.
59. Guillaume T, Rubinstein DB, Symann M. Immune reconstitution and immunotherapy after autologous hematopoietic stem cell transplantation. Blood 1998;92:1471-90.
60. Choyke PL, Zeman RK, Gootenberg JE, et al. Thymic atrophy and regrowth in response to chemotherapy: CT evaluation. Am J Radiol 1987;14:269-72.
61. Small EJ, Venook AP, Damon LE, Gallium-avid thymic hyperplasia in an adult after chemotherapy for Hodgkin disease. Cancer 1993;72:905-8.
62. Miniero R, Busca A, Leonardo F et al. Rebound thymic hyperplasia following high dose chemotherapy and allogeneic BMT. Bone Marrow Transplant 1993;11:67-70.
63. Chertoff J, Barth RA, Dickerman ID. Rebound thymic hyperplasia five years after chemotherapy for Wilm's tumor. Pediatr Radiol 1991;21:596-7.
64. + T-lymphocyte regeneration after intensive chemotherapy. N Engl J Med 1995;332:143-9.
65. Roederer M, De Rosa SC, Watanabe N, Herzenberg LA. Dynamics of fine T-cell subsets during HIV disease and after thymic ablation by mediastinal irradiation. Sem Immunol 1997;9:389-96.
66. Watanabe N, De Rosa SC, Cmelak A et al. Long-term depletion of naive T cells in patients treated for Hodgkin's disease. Blood 1997;90:3662-72.
67. Arstila TP, Casrouge A, Baron V et al. A direct estimate of the human αβ T cell receptor diversity. Science 1999; 286:958-61.
68. Lewis SM, Wu GE. The origins of V(D)J recombination. Cell 1997;88:159-62.
69. Douek DC, McFarland RD, Keiser PH et al. Changes in thymic function with age and during the treatment of HIV infection. Nature 1998;396:690-5.
70. Poulin JF, Viswanathan MN, Harris JM et al. Direct evidence for thymic function in adult humans. J Exp Med 1999;190:479-86.
71. Kong F, Chen CH, Cooper MD. Thymic function can be accurately monitored by the level of recent T cell emigrants in the circulation. Immunity 1998;8:97-104.
72. Zhang L, Lewin SR, Markowitz M et al. Measuring recent thymic emigrants in blood of normal and HIV-1-infected individuals before and after effective therapy. J Exp Med 1999;190:725-32.
73. Hatzakis A, Touloumi G, Karanicolas R et al. Effect of recent thymic emigrants on progression of HIV-1 disease. Lancet 2000;355:599-604.
74. Douek DC, Vescio RA, Betts MR et al. Assessment of thymic output in adults after haematopoietic stem-cell transplantation and prediction of T-cell reconstitution. Lancet 2000;355:1875-81.
75. Talvensaari K, Clave E, Douay C et al. A broad T-cell repertoire diversity and an efficient thymic function indicate a favorable long-term immune reconstitution after cord blood stem cell transplantation. Blood 2002;99:1458-64.
76. Savage WJ, Bleesing JJ, Douek D et al. Lymphocyte reconstitution following non-myeloablative hematopoietic stem cell transplantation follows two patterns depending on age and donor/recipient chimerism. Bone Marrow Transplant 2001;28:463-71.
77. Weinberg K, Blazar BR, Wagner JE et al. Factors affecting thymic function after allogeneic hematopoietic stem cell transplantation, Blood 2001;97:1458-66.
78. Napolitano LA, Grant RM, Deeks SG et al. Increased production of IL-7 accompanies HIV-1-mediated T-cell depletion: Implications for T-cell homeostasis. Nat Med 2001;7:73-9.
79. Bolotin F, Smogorzewska M, Smith S et al. Enhancement of thymopoiesis after bone marrow transplant by in vivo interleukin-7. Blood 1996;88:1887-94.
80. Mackall CL, Fry TJ, Bare C et al. IL-7 increases both thymic-dependent and thymic-independent T-cell regeneration after bone marrow transplantation Blood 2001;97:1491-7.
81. Welniak LA, Sun R, Murphy WJ. The role of growth hormone in T-cell development and reconstitution. J Leukoc Biol 2002;71:381-7.
82. Storek J, Witherspoon RP, Storb R. T cell reconstitution after bone marrow transplantation into adult patients does not resemble T cell development in early life. Bone Marrow Transplant 1995;16:413-25.
83. Muller-Hermelink HK, Sale GE, Borisch B, Storb R. Pathology of the thymus after allogeneic bone marrow transplantation in man. A histologic immunohistochemical study of 36 patients. Am J Pathol 1987;129:242-56.
84. Seemayer TA, Lapp WS, Bolande RP. Thymic involution in murine graft-versus-host reaction. Epithelial injury mimicking human thymic dysplasia. Am J Pathol 1977;88:199-33.
85. Lapp WS, Wechsler A, Kongshavn PA. Immune restoration of mice immunosuppressed by a graft-vs.-host reaction. Cell Immunol 1974;11:419-26.
86. Storek J, Gooley T, Witherspoon RP et al. Infectious morbidity in long-term survivors of allogeneic marrow transplantation is associated with low CD4 T cell counts. Am J Hematol 1997;54:131-8.
87. Jaffee BD, Claman HN. Chronic graft-versus-host disease (GVHD) as a model for scleroderma. I. Description of model systems. Cell Immunol 1983;77:1-12.
88. Hiesse C, Goldschmidt E, Santelli C et al. Membranous nephropathy in a bone marrow transplant recipient. Am J Kidney Dis 1988;11:188-91.
89. Reyes MG, Noronha F, Thomas W, Jr, Heredia R. Myositis of chronic graft versus host disease. Neurology 1983;33:1222-4.
90. Rosenberg ME, Vercellotti GM, Snover DC et al. Bronchiolitis obliterans after bone marrow transplantation. Am J Hematol 1985;18:325-8.
91. Fialkow PJ, Gilchrist C, Allison AC. Autoimmunity in chronic graft versus-host disease. Clin Exp Immunol 1973;13:479-86.
92. Desbarats J, Lapp WS. Thymic selection and thymic major histocompatibility complex class II expression are abnormal in mice undergoing graft-versus-host reactions. J Exp Med 1993;178:805-14.